SpringWorks Therapeutics Announces Nirogacestat Achieved
-- Results Showed Statistically Significant Improvement in Progression-Free Survival (PFS) Compared to Placebo (Hazard Ratio (HR) = 0.29; P < 0.001) -- -- Statistical Significance Was Also Achieved on All Key Secondary Endpoints,…